The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant enzalutamide (ENZA) and abiraterone acetate (AA) plus leuprolide acetate (LHRHa) versus AA+ LHRHa in localized high-risk prostate cancer (LHRPC).
 
Eleni Efstathiou
Honoraria - Astellas Pharma; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - AstraZeneca; Janssen Oncology; Sanofi; Tokai Pharmaceuticals
Research Funding - Janssen-Cilag
Travel, Accommodations, Expenses - Sanofi
 
John W. Davis
Honoraria - Astellas Pharma; Intuitive Surgical; Myriad Genetics
Speakers' Bureau - Myriad Genetics
Research Funding - GenomeDx; Hologic; Janssen
Travel, Accommodations, Expenses - Astellas Pharma; Intuitive Surgical; Myriad Genetics
 
Mark Anton Titus
No Relationships to Disclose
 
Brian Francis Chapin
No Relationships to Disclose
 
Amado J. Zurita
No Relationships to Disclose
 
Sijin Wen
No Relationships to Disclose
 
Elsa M. Li Ning Tapia
No Relationships to Disclose
 
Anh Hoang
No Relationships to Disclose
 
Paul Gettys Corn
No Relationships to Disclose
 
Xuemei Wang
No Relationships to Disclose
 
Francine Whittington
No Relationships to Disclose
 
Patricia Troncoso
No Relationships to Disclose
 
Christopher Logothetis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Churchill Pharmaceuticals; Clovis Oncology; Helsinn Healthcare; Johnson & Johnson; Novartis; Pfizer; Sanofi
Research Funding - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Cougar Biotechnology; Exelixis; GlaxoSmithKline; Johnson & Johnson; Karyopharm Therapeutics; Novartis; Pfizer; Sanofi